26
Sep
Washington/New Delhi: In a dramatic shift aimed at reshaping the U.S. pharmaceutical manufacturing landscape, former U.S. President Donald Trump has announced a 100% tariff on all imported branded and patented medicines, effective October 1, 2025. The sweeping move is likely to rattle the global pharmaceutical trade, with India’s pharma exports particularly vulnerable. Trump made the announcement via his social media platform, Truth Social, stating that the tariff will apply to any branded pharmaceutical product unless the manufacturer is actively building a production facility within the United States. “Companies importing branded or patented pharmaceutical products will face a 100% tariff unless…
